+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

KOL Perspectives: Patient Niches in IBD

  • ID: 4701808
  • Drug Pipelines
  • September 2018
  • Region: Global
  • 36 pages
  • GlobalData

FEATURED COMPANIES

  • AbbVie
  • Atlantic
  • Gilead
  • Janssen
  • Takeda
  • MORE
Summary

This KOL Insight briefing focuses on KOLs views of Patient Niches in IBD.

Questions topics -
  • Perceptions on patient niches and treatments of fistulizing Crohn’s disease
  • Perceptions on patient niches and treatments in small-bowel Crohn’s disease
  • Perceptions on patient niches and treatments in pouchitis
  • Perceptions on patient niches and treatments in acute severe UC
Key Highlights
  • Most KOLs were unsure of the efficacy profile for JAK inhibitors in the treatment of fistulizing Crohn’s disease
  • Most KOLs flagged the need for a targeted therapy that prevents long-term complications of SBCD
  • Most KOLs noted that up to 50% of UC patients experience pouchitis after surgery, with antibiotics typically used before biologics.
Scope
  • The insight briefing is based on Sociable Pharma’s analysis of primary research with our IBD key opinion leaders (KOLs).
In total, we conducted interviews with 10 KOLs -
  • 5 Europe-based & 5 N. America-based
  • Interviews performed during July 2018
KOL data is analyzed to produce -
  • Charts summarizing KOL opinions
  • Chart call-outs of key information & details
  • KOL quotes
  • Summary of KOL reporting trends
  • Insight from Sociable Pharma's analysts
Reasons to Buy
  • Combines Qualitative & semi-quantitative insight from key opinion leaders on Patient Niches in IBD
  • Includes insight & recommendations from our disease-specific healthcare analysts
  • Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of IBD
  • Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie
  • Atlantic
  • Gilead
  • Janssen
  • Takeda
  • MORE
  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Janssen
  • Takeda
  • AbbVie
  • Gilead
  • Atlantic
Note: Product cover images may vary from those shown
Adroll
adroll